News
Capital One (COF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Capital One (COF) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives
Community Financial System (CBU) Earnings Expected to Grow: Should You Buy?
The market expects Community Financial System (CBU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known
Badger Meter (BMI) Reports Next Week: Wall Street Expects Earnings Growth
Badger Meter (BMI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives
Canadian National (CNI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Canadian National (CNI) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Analysts Estimate Baker Hughes (BKR) to Report a Decline in Earnings: What to Look Out for
The market expects Baker Hughes (BKR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook
Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for
The market expects Coca-Cola (KO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is
Earnings Preview: Avery Dennison (AVY) Q2 Earnings Expected to Decline
The market expects Avery Dennison (AVY) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Philip Morris (PM) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
Earnings Preview: General Motors (GM) Q2 Earnings Expected to Decline
General Motors (GM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Here's What Key Metrics Tell Us About Citigroup (C) Q2 Earnings
For the quarter ended June 2025, Citigroup (C) reported revenue of $21.67 billion, up 7.6% over the same period last year. EPS came in at $1.96, compared to $1.52 in the year-ago quarter.
The
Best Momentum Stocks to Buy for July 15th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 15th:
Futu Holdings Limited FUTU: This online brokerage and wealth management platform
Growth ETFs Set New Records, Brush Off Tariff Headwinds
Wall Street has been showing huge resilience with the return of tariff threats. The Nasdaq Composite Index once again made a new record close, driven by the AI boom and confidence in corporate
Trade Tensions Hurting ZIM's Outlook: What's the Road Ahead?
ZIM Integrated Shipping ZIM, which had a stupendous 2024 courtesy of the Red Sea Shipping crisis-induced elevated freight rates, has been suffering this year mainly due to the tariff tensions.
The
Can Nebius Monetize Its Bets on ClickHouse, Avride and Toloka?
Nebius Group N.V. NBIS is a Europe-based AI-infrastructure company. The stock price has seen a meteoric rise (up 146.4% in the past three months), outperforming the S&P 500’s 18.9% growth. NBIS is
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?
Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 5.5% over the past four weeks to close the last trading session at $34.71, but there could still be a solid upside left in the stock
Wall Street Analysts Believe Hillman Solutions Corp. (HLMN) Could Rally 40.8%: Here's is How to Trade
Shares of Hillman Solutions Corp. (HLMN) have gained 13.1% over the past four weeks to close the last trading session at $7.77, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?
ARS Pharmaceuticals, Inc. (SPRY) closed the last trading session at $17.9, gaining 18.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Predict a 40.78% Upside in Navigator Holdings (NVGS): Here's What You Should Know
Navigator Holdings (NVGS) closed the last trading session at $15.45, gaining 7.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect?
Shares of LENZ Therapeutics, Inc. (LENZ) have gained 17% over the past four weeks to close the last trading session at $33.73, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
Astrana Health, Inc. (ASTH) closed the last trading session at $25.12, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?
Shares of Rapt Therapeutics (RAPT) have gained 5.8% over the past four weeks to close the last trading session at $8.72, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet
Exact Sciences (EXAS) closed the last trading session at $54.3, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe TeraWulf (WULF) Could Rally 43.25%: Here's is How to Trade
Shares of TeraWulf Inc. (WULF) have gained 18% over the past four weeks to close the last trading session at $5.11, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict an 86.55% Upside in Zevra Therapeutics (ZVRA): Here's What You Should Know
Zevra Therapeutics (ZVRA) closed the last trading session at $12.79, gaining 40.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Artisan Partners Asset Management (APAM)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Artisan Partners Asset Management Inc. (APAM) could be a good stock pick from a technical perspective. APAM recently experienced a "golden cross" event


